Ran Frenkel, RPh
Chief Development Operations Officer
Ran joined Karyopharm in October 2014. He manages Karyopharm Europe GmbH, a subsidiary of Karyopharm, which provides the necessary corporate structure to support Karyopharm’s expanded clinical and regulatory activities in Europe. As Chief Development Operations Officer, Ran is also responsible for the corporate global development operations across the entire portfolio. In this capacity, he also manages the clinical departments including Clinical Operations, Medical Writing, Data Management, and Data Analysis.
Ran has more than 20 years of experience in the international biopharmaceutical industry encompassing clinical, regulatory, business development and commercial operations activities. Prior to joining Karyopharm Europe GmbH, he held a number of senior management roles in Europe, Israel and the United States, most recently as Managing Director EMEA for Clinipace Worldwide, an international clinical research organization, where he was responsible for the overall management of the organization in Europe, the Middle East and Africa. Prior to joining Clinipace Worldwide, Ran established and managed the Israeli office of PFC Pharma Focus AG, which was acquired by Clinipace in 2011, and where he held the position of Managing Director at Actelion Pharmaceuticals with responsibility for all science and business affairs of the company in Israel.
A registered pharmacist, Ran serves on the advisory board of Musli Thyropeutics and holds a Bachelor of Science in Pharmacy from the Hebrew University of Jerusalem.
Vice President, Investor and Public Relations